Validity of administering the child development evaluation test through telemedicine to children aged 18-72 months
Boletín Médico del Hospital Infantil de México · 2025
DOI: 10.24875/bmhim.24000163 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Boletín Médico del Hospital Infantil de México, 2025. Verfasst von Ilma R Torres-Escobar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Developmental-Behavioral Pediatrics Service, Hospital Infantil de México Federico Gómez. Hauptthemen laut MEDLINE: Child Development, Developmental Disabilities, Mass Screening.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Early childhood development is a complex process that requires reliable tools for the timely detection of alterations that may affect a child’s progress. The Child Development Evaluation test (EDI, in its Spanish acronym) is a screening test developed and validated in Mexico to be administered in person by a professional. The objective is to evaluate the validity of administering the EDI test through telemedicine in terms of its diagnostic concordance with the face-to-face modality.
Methods
This analytical, prospective, and cross-sectional study included patients aged 18-72 months and was conducted at a tertiary care hospital in Mexico City. The test was administered through telemedicine and subsequently in person. In addition, sensitivity and specificity data were reported with confidence interval of 95% (95% CI). The face-to-face evaluator was blinded to the telemedicine results.
Results
Fifty children with a median age of 47 months participated in the study. A sensitivity of 100% (95% CI, 91-100) and specificity of 100% (95% CI, 70-100) overall were obtained. Language was the higher area with a sensitivity of 100 (95% CI: 91-100) and specificity of 90 (59-98); the results for the other areas are shown. The lowest sensitivity was neurological examination (67; CI 95%: 30-90) but has the highest specificity (98; CI 95%: 88-99).
Conclusion
The EDI test implemented through telemedicine shows high correlation with the face-to-face modality, maintaining high sensitivity and specificity. These results make it an appropriate method for screening children of this age, although further larger studies are needed to corroborate it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Developmental-Behavioral Pediatrics Service, Hospital Infantil de México Federico Gómez.
- Evidence Analysis and Synthesis Research Unit, Hospital de Pediatría Centro Médico Nacional Siglo XXI, Instituto Méxicano del Seguro Social.
- General Direction, Comisión Coordinadora de los Institutos Nacionales de Salud y Hospitales de Alta Especialidad.
- Clinical and Health Psychology Coordination, Facultad de Psicología, Universidad Nacional Autónoma de México.
- Investigación Biomédica, Centro Médico Nacional 20 de Noviembre, Instituto de Servicios y Seguridad Social para los Trabajadores del Estado. Mexico City, Mexico.
Zitieren
APA
Torres-Escobar, I. R., Villasis-Keever, M. Á., Zapata-Tarrés, M. M., Hernández-Trejo, L. A., Delaflor-Wagner, C. A., & Rizzoli-Córdoba, A. (2025). Validity of administering the child development evaluation test through telemedicine to children aged 18-72 months. Boletín Médico del Hospital Infantil de México. https://doi.org/10.24875/bmhim.24000163
Vancouver
Torres-Escobar IR, Villasis-Keever MÁ, Zapata-Tarrés MM, Hernández-Trejo LA, Delaflor-Wagner CA, Rizzoli-Córdoba A. Validity of administering the child development evaluation test through telemedicine to children aged 18-72 months. Boletín Médico del Hospital Infantil de México. 2025. doi:10.24875/bmhim.24000163
BibTeX
@article{TorresEscobar2025,
author = {Torres-Escobar, Ilma R and Villasis-Keever, Miguel Á and Zapata-Tarrés, Martha M and Hernández-Trejo, Laura A and Delaflor-Wagner, Christian A and Rizzoli-Córdoba, Antonio},
title = {Validity of administering the child development evaluation test through telemedicine to children aged 18-72 months},
journal = {Boletín Médico del Hospital Infantil de México},
year = {2025},
doi = {10.24875/bmhim.24000163}
}
EUVIMED